Mydriasis induction;Cycloplegic refraction;Amblyopia

Mydriatics/Cycloplegics

"Onset of action: Ophthalmic solution: Within minutes; maximum effect: within hoursBioavailability: Ophthalmic solution: 64% ± 29% (range: 19% to 95%)"

Hypersensitivity to atropine or any component of the formulation; primary glaucoma or tendency toward narrow anterior chamber angle glaucoma (ointment only).

Atropine is systemically available following ophthalmic administration. If ophthalmic agents are needed during pregnancy, the minimum effective dose should be used in combination with punctual occlusion to decrease potential exposure to the fetus

Micromedex: Infant risk cannot be ruled out.

Blurred vision, decreased lacrimation, eye irritation, eyelid edema, eye pain, papillary conjunctivitis, photophobia, stinging of eyes, superficial keratitis

1~2 drop(s), 1-4 times daily.

1~2 drop(s), 1-4 times daily.

There are no dosage adjustments provided in the manufacturer's labeling

There are no dosage adjustments provided in the manufacturer's labeling

Store between 15 and 30 degrees C